Hutchmed (China) Limited 20 November 2024 HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee Hong Kong, Shanghai & Florham Park, NJ...
Hutchmed (China) Ltd on Thursday said it will receive a USD20 million payment from its partner Takeda Pharmaceutical ...
Hutchmed (China) Limited 31 October 2024 Total Voting Rights Hong Kong, Shanghai, & Florham Park, NJ – Thursday, October 31, 2024: HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:...
Hutchmed (China) Limited 21 October 2024 Vesting of awards under the Long Term Incentive Plan Hong Kong, Shanghai & Florham Park, NJ - Monday, October 21, 2024: HUTCHMED (China) Limited...
Hutchmed China Ltd on Wednesday said that Tagrisso plus Orpathys showed a high clinically meaningful response rate in ...
Hutchmed (China) Limited 16 October 2024 HUTCHMED Announces that TAGRISSO® plus ORPATHYS® demonstrated high, clinically meaningful response rate in lung cancer patients with high levels of...
Takeda Pharmaceutical Co Ltd on Tuesday said it landed an approval for its Fruzaqla drug in Japan. The drug has bee ...
Hutchmed (China) Limited 24 September 2024 HUTCHMED Announces Japan Approval for FRUZAQLA® (fruquintinib) Received by Takeda - Approval based on results from global Phase III FRESCO-2...
Hutchmed (China) Ltd announced on Friday that it has voluntarily withdrawn its supplemental new drug application for ...
Hutchmed (China) Limited 30 August 2024 Total Voting Rights Hong Kong, Shanghai, & Florham Park, NJ - Friday, August 30, 2024: HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM: HCM;...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 11 | 4.10447761194 | 268 | 290 | 260 | 59536 | 272.03316671 | DE |
4 | -57 | -16.9642857143 | 336 | 336 | 260 | 67063 | 291.31968388 | DE |
12 | 6 | 2.1978021978 | 273 | 336 | 242 | 139840 | 295.19971089 | DE |
26 | -33 | -10.5769230769 | 312 | 336 | 242 | 99745 | 294.63179424 | DE |
52 | -17 | -5.74324324324 | 296 | 353 | 190.4 | 88901 | 287.58880592 | DE |
156 | -191 | -40.6382978723 | 470 | 556 | 130 | 105330 | 273.87711253 | DE |
260 | -89 | -24.1847826087 | 368 | 656 | 130 | 101730 | 348.86820717 | DE |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約